1. Home
  2. AIRS vs PLX Comparison

AIRS vs PLX Comparison

Compare AIRS & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AirSculpt Technologies Inc.

AIRS

AirSculpt Technologies Inc.

BUY

Current Price

$1.23

Market Cap

182.4M

Sector

Health Care

ML Signal

BUY

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$2.55

Market Cap

207.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRS
PLX
Founded
2012
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
182.4M
207.1M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
AIRS
PLX
Price
$1.23
$2.55
Analyst Decision
Hold
Analyst Count
3
0
Target Price
★ $4.50
N/A
AVG Volume (30 Days)
826.2K
★ 840.6K
Earning Date
11-06-2026
08-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.27
Revenue
★ $151,818,000.00
$52,744,000.00
Revenue This Year
N/A
$55.77
Revenue Next Year
$2.65
N/A
P/E Ratio
★ N/A
$9.57
Revenue Growth
N/A
★ N/A
52 Week Low
$1.16
$1.65
52 Week High
$12.00
$3.19

Technical Indicators

Market Signals
Indicator
AIRS
PLX
Relative Strength Index (RSI) 24.50 42.21
Support Level N/A $2.21
Resistance Level $3.31 $2.75
Average True Range (ATR) 0.13 0.10
MACD -0.00 -0.03
Stochastic Oscillator 8.57 7.41

Price Performance

Historical Comparison
AIRS
PLX

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: